Skip to content

A Long-Term Follow-up Study for Subjects Previously Treated with A Century Therapeutics Cellular Therapy Product

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-520222-11-00
Acronym
CNTY-LTFU-01
Enrollment
15
Registered
2025-07-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematological or solid tumor malignancies or autoimmune diseases

Interventions

None listed

Sponsors

Century Therapeutics Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

France, Germany, Italy

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026